Scienture Holdings, Inc. (SCNX) Fair Value 2026

SCNX · Pharmaceutical Retailers ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.2 /10

32 fundamental signals · 0 models active

Value Trap Risk

WARN (53/100)

Quick Summary — As of 2026-08-28, Scienture Holdings, Inc. (SCNX) trades at $0.39. QOC: 5.2/10. Value Trap Risk: 53/100 (WARN). 0/13 models active.

Key Facts

Ticker
SCNX
Price
$0.39
Quality Score
5.2/10
Value Trap Risk
53/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Value Trap score of 53 suggests caution despite apparent undervaluation

What Fair Value Does Each Model Give SCNX?

0 Intrinsic Value Models vs. Current Price ($0.39)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Scienture Holdings, Inc. (SCNX) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Scienture Holdings, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About SCNX?

0 of 13 models are currently active for SCNX. See which stocks rank higher →

How Does SCNX Rank in Pharmaceutical Retailers?

Among 9 Pharmaceutical Retailers stocks, SCNX ranks #6 by Quality of Company score. CirclFi's QOC score of 5.2/10 evaluates 32 fundamental signals. A score of 5.2 reflects mixed fundamentals.

The Pharmaceutical Retailers sector introduces analytical considerations specific to healthcare company businesses. For Scienture Holdings, Inc., metrics like pipeline depth and stage distribution provide important context that general-purpose valuation models may underweight.

Is SCNX a Value Trap?

CirclFi's Value Trap algorithm assigns SCNX a score of 53/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Scienture Holdings, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Scienture Holdings, Inc. scores 5.2 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SCNX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Scienture Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Pharmaceutical Retailers Stocks Should You Also Analyze?

8 related Pharmaceutical Retailers stocks with 13-model coverage

BHICBioScience Health Innovations IQOC 6.8PETSPetMed Express, Inc.QOC 6.2HITIHigh Tide Inc.QOC 5.8SHFHScientist Home Future Health LimitedQOC 5.6DHTIDalrada Technology Group Inc.QOC 5.4PMHSPolomar Health Services, Inc.QOC 5.2POMPomdoctor LimitedQOC 4.9RDGTRidgetech, Inc.QOC 1.8

Read investment analysis: BHIC · PETS · HITI · SHFH · DHTI · PMHS · POM · RDGT

Which Other Stocks Have a Similar Quality Score to SCNX?

6 companies across all industries closest to SCNX’s Quality of Company score of 5.2/10.

SCLXScilex Holding CompanyQOC 5.2NEUPNeuphoria Therapeutics Inc.QOC 5.2PAPLPineapple Financial Inc.QOC 5.2ALDXAldeyra Therapeutics, Inc.QOC 5.2ALMSAlumis Inc.QOC 5.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SCLX · NEUP · PAPL · ALDX · ALMS · NVDA

What Else Do Investors Ask About Scienture Holdings, Inc.’s Valuation?

What is Scienture Holdings, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Scienture Holdings, Inc. (SCNX). The Quality of Company score is 5.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SCNX overvalued or undervalued right now?

At $0.39, 0 of 0 active models suggest SCNX may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Scienture Holdings, Inc.'s business model in Pharmaceutical Retailers.

What does a Quality of Company score of 5.2 mean for SCNX?

Scienture Holdings, Inc.'s QOC of 5.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on SCNX?

CirclFi analyzes SCNX with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is SCNX a value trap in 2026?

Scienture Holdings, Inc.'s Value Trap score is 53/100 (WARN). This elevated score suggests the stock may look undervalued but faces deteriorating fundamentals — declining margins, rising debt, or shrinking revenue could make the apparent discount deceptive. Browse our ranked stock lists to compare value-trap scores across industries. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Scienture Holdings, Inc. (SCNX) a Quality of Company score of 5.2/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/SCNX/ · Methodology
Primary sources for this SCNX valuation
  • Financial statements: Scienture Holdings, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001382574) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SCNX as of ; valuations recomputed .